Unknown

Dataset Information

0

N6-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1.


ABSTRACT:

Objective

Cervical cancer is a frequently encountered gynecological malignancy as a major contributor to cancer-related deaths in women. This study focuses on how miR-193b promotes cervical cancer aggressiveness as well as the role of m6A in miR-193b silencing.

Methods

Cervical cancer samples and the matching adjacent normal cervical tissues were used to determine the significance of miR-193b in cervical cancer. The CCK-8 assay, cell cycle analysis, qRT-PCR, Western blot assay, IHC, RIP, and xenograft models were utilized to explore the impact of miR-193b in cervical cancer and how m6A regulates miR-193b expression. Luciferase reporter assays, qRT-PCR, and Western blotting were enlisted to study the interaction between miR-193b and CCND1.

Results

Our study suggested that lower miR-193b expressions were strongly linked to more advanced cervical cancer stages and the presence of deeper stromal invasion. miR-193b functions as a tumor suppressor that is regulated by m6A methylation in cervical tumors. METTL3 modulates miR-193b mature process in an m6A-dependent manner. Reintroduction of miR-193b profoundly inhibits tumorigenesis of cervical cancer cells both in vivo and in vitro through CCND1 targeting.

Conclusions

m6A associated downregulation of miR-193b promotes cervical cancer aggressiveness by targeting CCND1.

SUBMITTER: Huang C 

PROVIDER: S-EPMC8222573 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5743558 | biostudies-literature
| S-EPMC7585578 | biostudies-literature
| S-EPMC6717747 | biostudies-literature
| S-EPMC9832623 | biostudies-literature
| S-EPMC6488183 | biostudies-literature
| S-EPMC6126698 | biostudies-literature
| S-EPMC6478927 | biostudies-literature
| S-EPMC7169941 | biostudies-literature
| S-EPMC7547657 | biostudies-literature
| S-EPMC4754993 | biostudies-literature